Sibling disability risk at onset and during disease progression in familial multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 9, 2011, Pages 1060-1066

  Wellek, Anne ^a   Korsukewitz, Catharina ^a,b   Bach, Jan P ^a   Schock, Sabine ^a   Eienbröker, Christian ^a   Seitz, Florian ^a   Spengler, Anna ^a   Hemmer, Bernhard ^c   Schlegel, Kerstin ^a   Oertel, Wolfgang H ^a   Sommer, Norbert ^d   Tackenberg, Björn ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Klinikum Christophsbad   (Germany)

Author keywords

genetics; multiple sclerosis; progressive; relapsing remitting

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MULTIPLE SCLEROSIS; ONSET AGE; RELAPSE; REMISSION; SIBLING; SURVIVAL; WILCOXON SIGNED RANKS TEST;

EID: 84860405903     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511405088     Document Type: Article

References (35)

1. Fromont A, Binquet C, Sauleau EA, et al. Geographic variations of multiple sclerosis in France. Brain. 2010 ; 133: 1889-1899
2. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature. 1995 ; 377: 150-151
3. Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity. Nat Rev Immunol. 2009 ; 9: 246-258
4. Sadovnick AD, Macleod PM. The familial nature of multiple sclerosis: empiric recurrence risks for first, second-, and third-degree relatives of patients. Neurology. 1981 ; 31: 1039-1041 (Pubitemid 11061749)
5. Ebers GC, Bulman DE, Sadovnick AD, et al. A population-based study of multiple sclerosis in twins. N Engl J Med. 1986 ; 315: 1638-1642 (Pubitemid 17052896)
6. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 2008 ; 7: 268-277 (Pubitemid 351222732)
7. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A. 2003 ; 100: 12877-12882 (Pubitemid 37339993)
8. Thorpe JW, Mumford CJ, Compston DA, et al. British Isles survey of multiple sclerosis in twins: MRI. J Neurol Neurosurg Psychiatry. 1994 ; 57: 491-496 (Pubitemid 24118148)
9. Lincoln MR, Ramagopalan SV, Chao MJ, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A. 2009 ; 106: 7542-7547
10. Ramagopalan SV, Ebers GC. Epistasis. Multiple sclerosis and the major histocompatibility complex. Neurology. 2009 ; 72: 566-567
11. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008 ; 131: 808-817 (Pubitemid 351294716)
12. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005 ; 4: 281-288 (Pubitemid 40545039)
13. Brassat D, Azais-Vuillemin C, Yaouanq J, et al. Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group. Neurology. 1999 ; 52: 1632-1636 (Pubitemid 29220639)
14. Chataway J, Mander A, Robertson N, et al. Multiple sclerosis in sibling pairs: an analysis of 250 families. J Neurol Neurosurg Psychiatry. 2001 ; 71: 757-761 (Pubitemid 33121917)
15. Hensiek AE, Seaman SR, Barcellos LF, et al. Familial effects on the clinical course of multiple sclerosis. Neurology. 2007 ; 68: 376-383 (Pubitemid 46184215)
16. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001 ; 50: 121-127
17. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
19. Sadovnick AD, Yee IM, Guimond C, Reis J, Dyment DA, Ebers GC. Age of onset in concordant twins and other relative pairs with multiple sclerosis. Am J Epidemiol. 2009 ; 170: 289-296
20. Ebers GC, Koopman WJ, Hader W, et al. The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain. 2000 ; 123: 641-649 (Pubitemid 30099546)
21. Nielsen NM, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol. 2005 ; 162: 774-778 (Pubitemid 41437764)
22. Weinshenker BG, Bulman D, Carriere W, Baskerville J, Ebers GC. A comparison of sporadic and familial multiple sclerosis. Neurology. 1990 ; 40: 1354-1358 (Pubitemid 20291639)
23. Fernandez-Perez MJ, Barakat O, Garcia-Moreno JM, et al. Clinical features of familial multiple sclerosis in Spain. Rev Neurol. 1999 ; 29: 693-696
24. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006 ; 129: 595-605 (Pubitemid 43278222)
25. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006 ; 129: 584-594 (Pubitemid 43278221)
26. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain. 2010 ; 133: 1914-1929
27. Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol. 2006 ; 5: 343-354
28. Koch M, Kingwell E, Rieckmann P, Tremlett H. The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010 ; 81: 1039-1043
29. Koch M, Uyttenboogaart M, Heerings M, Heersema D, Mostert J, De Keyser J. Progression in familial and nonfamilial MS. Mult Scler. 2008 ; 14: 300-306 (Pubitemid 351676424)
30. Koch M, Zhao Y, Yee I, et al. Disease onset in familial and sporadic primary progressive multiple sclerosis. Mult Scler. 2010 ; 16: 694-700
31. Sadovnick AD, Yee IM, Ebers GC, Risch NJ. Effect of age at onset and parental disease status on sibling risks for MS. Neurology. 1998 ; 50: 719-723
32. Oturai AB, Ryder LP, Fredrikson S, et al. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs. Mult Scler. 2004 ; 10: 5-8 (Pubitemid 38100520)
33. Bulman DE, Sadovnick AD, Ebers GC. Age of onset in siblings concordant for multiple sclerosis. Brain. 1991 ; 114: 937-950
34. Hupperts R, Broadley S, Mander A, Clayton D, Compston DA, Robertson NP. Patterns of disease in concordant parent-child pairs with multiple sclerosis. Neurology. 2001 ; 57: 290-295 (Pubitemid 32667363)
35. Polman C, Kappos L, Freedman MS, et al. Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. J Neurol. 2008 ; 255: 480-487